Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...